Molecular Residual Disease (MRD) and Liquid Biopsy Assessment in CRC and Other GI Malignancies

We are excited to share recordings of the Molecular Residual Disease (MRD) and Liquid Biopsy Assessment in CRC and Other GI Malignancies session from the Inaugural GI Cancers US Focus Meeting 2025, held at the Marina del Rey Marriott in California on July 25–26, 2025.

Enroll for Free

Course curriculum

1. Christopher Lieu, MD – A Predictive Role for MRD in Early-stage CRC
2. Bassel El-Rayes, MD – MRD as a Tool to Monitor Response in GI Malignancies
3. Daniel H. Ahn, MD – The Role of “Liquid Biopsies” in GI Malignancies – When & Why?
4. Panel Discussion & Take-home Points from Day 2

About this course

Free
4 lessons
1 hour of video content

Meeting Highlights

The Inaugural GI Cancers US Focus Meeting 2025 was kindly supported by

Our supporters part sponsored the meeting. Our supporters had no influence or input in the event.

Molecular Residual Disease (MRD) and Liquid Biopsy Assessment in CRC and Other GI Malignancies

Course curriculum

Molecular Residual Disease (MRD) and Liquid Biopsy Assessment in CRC and Other GI Malignancies

About this course

Meeting Highlights

The Inaugural GI Cancers US Focus Meeting 2025 was kindly supported by

Gold

Silver

Additional support from